The 2022 CAPCaT Big Company/Little Company Showcase speaker lineup will feature authorities on topics that are top-of-mind among current and future medtech innovators: the forward-looking state of the market and the challenge of health equity.Continue reading
For the third year, M2D2 and the Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood, and Sleep Disorders will present their Big Company/Little Company Showcase.
Happening virtually on Thursday, June 16 from 9am to 1:30 ET, the Showcase is a high-value informational and networking event for life sciences startups seeking to initiate conversations about strategic partnerships with suitable corporate entities.Continue reading
This past April, the 10 medical device startups in Cohort 2 of the IMPACT Accelerator Program virtually pitched their solutions to a panel of industry leaders. Our Cycle 2 cohort spent 10 weeks working with experts at BARDA and M2D2 partners to improve their pitch and advance their innovation.Continue reading
The first in-person $200K Challenge season in almost three years was an overwhelming success, and a joy to experience with all of you. We were joined by a number of leaders in life sciences, entrepreneurs, and medical device innovators in both Lowell and Boston to learn more about this year’s Finalists.
15 Finalists pitched their innovations on March 22nd at the UMass Lowell iHub during the $200K Challenge Pitch-Off event. On April 6th, we came back together in Boston to find out who would win a share of the $200,000 in sponsor-provided, in-kind support. Even more exciting? Who would win the Grand Prizes – $50,000 in non-dilutive funding from the Massachusetts Life Sciences Center and $25,000 in cash funding from M2D2.Continue reading
15 finalists have been selected from more than 150 applicants for the 11th Annual M2D2 $200K Challenge.
LOWELL, Massachusetts – On Thursday, March 10th, the University of Massachusetts Medical Device Development Center (M2D2) announced the finalists in its 11th annual $200K Challenge after reviewing the 150+ applications.Continue reading
Cycle 2 of the IMPACT Accelerator program is well underway as the ten selected startups work with representatives from the current Cycle sponsor, BARDA, to prepare for the pitch-off event on April 21st.
For Cycle 2, our sponsors’ Areas of Interest focused on developing digital health solutions to improve at-home care, early-disease detection devices, and host-based therapeutics. In January, we worked with BARDA to choose 10 highly innovative, early-stage medtech startups to join Cohort 2.Continue reading
In December of last year, the 10 medical device startups selected for the first IMPACT Accelerator program pitched their solutions to a panel of industry experts. Our Cycle 1 cohort spent 12 weeks working with life sciences experts, local mentors, and M2D2 resources to improve their pitch and advance their innovation.Continue reading
Over the last two years, we have been unable to come together to celebrate the $200K Challenge, and the startups involved in it. Luckily, we were still able to work virtually with innovative entrepreneurs around the country to help advance their innovations.
We are beyond thrilled to announce that this year, the $200K Challenge Pitch-Off will take place in-person, at M2D2. As our first major hybrid event in two years, we are excited – and cautious. We will have precautions in place and will continue to monitor the current situation to ensure everyone’s safety – stay updated by checking our Challenge website and subscribing to the M2D2 email.Continue reading
On December 9th, members of the 1st IMPACT Cohort joined the M2D2 team for a night of networking with key leaders in the Massachusetts healthcare innovation ecosystem. During this in-person event, IMPACT startups shared lightning pitches of their innovations and met with partners and sponsors of M2D2.Continue reading
10 startups have been selected to participate in the first cohort of the IMPACT Accelerator Program.
This week, M2D2 announced the finalists for its IMPACT Accelerator Program, a recently launched 12-week program designed to help early-stage companies advance their innovation. These 10 finalists will work closely with M2D2 and its network of experts, receiving 1-on-1 mentorship, education workshops, and access to lab equipment. After the 12-week program, the startups will be part of a public pitch event, where other life sciences startups and investors can learn more about their innovation.Continue reading